1. Prediction of the intestinal resistome by a three-dimensional structure-based method
- Author
-
Willem van Schaik, Kevin Weiszer, Nicolas Maziers, Hervé M. Blottière, Luis Máiz, Nicolas Pons, Fernando Baquero, S. Dusko Ehrlich, Bruno Fantin, José L. Martínez, Amine Ghozlane, Julien Tap, Malbert R. C. Rogers, Pierre Leonard, Rob J. L. Willems, Anne-Sophie Alvarez, Florence Haimet, Etienne Ruppé, Sara Hernando-Amado, Victoire de Lastours, Alexandre G. de Brevern, Tiphaine Goulenok, Ingrid Wieder, Xinglin Zhang, Antoine Andremont, Trinidad Cuesta, Véronique Léjard, Jean-Michel Batto, Aline Letur, Nawal Amor, Joël Doré, Val F. Lanza, Teresa M. Coque, Florence Levenez, Irene Clares, Sean Kennedy, MetaGenoPolis, Institut National de la Recherche Agronomique (INRA), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Hub Bioinformatique et Biostatistique - Bioinformatics and Biostatistics HUB, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Biomics, Centre de Recherche et Innovation Technologique (CITECH), Institut Pasteur [Paris] (IP)-Institut Pasteur [Paris] (IP), Centro Nacional de Biotecnología [Madrid] (CNB-CSIC), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Instituto Ramon y Cajal de Investigacion Sanitaria [Madrid, Spain] (IRYCIS), Universidad de Alcalá - University of Alcalá (UAH), CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Universitario Ramón y Cajal [Madrid], Service de Médecine Interne [AP-HP, CHU Beaujon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Bactériologie [AP-HP Hôpital Bichat-Claude Bernard], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University Medical Center [Utrecht], University of Birmingham [Birmingham], Biologie Intégrée du Globule Rouge (BIGR (UMR_S_1134 / U1134)), Institut National de la Transfusion Sanguine [Paris] (INTS)-Université de La Réunion (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Université des Antilles (UA)-Université Paris Cité (UPCité), King‘s College London, The project was funded in part by the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) under grant agreement number 282004, EvoTAR. IRYCIS authors acknowledge the European Development Regional Fund ‘A way to achieve Europe’ for co-founding the Spanish R&D National Plan 2012–2019 Work (PI15-0512), CIBER (CIBERESP, CB06/02/0053) and the Government of Madrid (InGeMICS- B2017/BMD-3691). V.F.L. was further funded by a Research Award Grant 2016 of the European Society for Clinical Microbiology and Infectious Diseases., The authors are grateful to the GENOTOUL (Toulouse, France), GENOUEST (Rennes, France), ABIMS (Roscoff, France), MIGALE (Jouy-en-Josas) and TGCC-GENCI (Institut Curie) calculation clusters. The authors also thank B. Perichon (Institut Pasteur, Paris, France) for providing ARD sequences from Acinetobacter baumannii, P. Siguier (CNRS, Toulouse, France) for helping the search of insertion sequences with ISfinder, J. Guglielmini (Institut Pasteur, Paris, France) for his assistance in finding conjugative elements, S. Volant (Institut Pasteur, Paris, France) for the design of the statistical model in SHAMAN, T. Jové (University of Limoges, France) for his assistance in finding integrons, M. Petitjean (IAME Research Center, Paris, France) for her assistance in bioinformatic analyses, and F. Plaza-Oñate and M. Almeida for their help with MSPs., European Project: 282004,EC:FP7:HEALTH,FP7-HEALTH-2011-single-stage,EVOTAR(2011), European Commission, Instituto de Salud Carlos III, Comunidad de Madrid, European Society of Clinical Microbiology and Infectious Diseases, Kennedy, Sean, Evolution and Transfer of Antibiotic Resistance - EVOTAR - - EC:FP7:HEALTH2011-10-01 - 2015-09-30 - 282004 - VALID, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris]-Institut Pasteur [Paris], Biocomputing Unit [Madrid], and Institut National de la Transfusion Sanguine [Paris] (INTS)-Université de La Réunion (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Université des Antilles (UA)-Université de Paris (UP)
- Subjects
ARDS ,Protein Conformation ,microbiome ,Drug resistance ,Antimicrobial resistance ,Applied Microbiology and Biotechnology ,MESH: Anti-Bacterial Agents/pharmacology ,MESH: Intestines/microbiology ,bacteria ,[INFO.INFO-BI] Computer Science [cs]/Bioinformatics [q-bio.QM] ,Genetics ,MESH: Protein Conformation ,0303 health sciences ,antibiotic-resistance genes ,MESH: Gastrointestinal Microbiome/genetics ,tool ,alignment ,Anti-Bacterial Agents ,3. Good health ,MESH: Bacteria/drug effects ,Intestines ,[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology ,Enterotype ,reveals ,MESH: Bacterial Proteins/chemistry ,Microbiology (medical) ,reservoir ,Immunology ,MESH: Bacteria/genetics ,Biology ,MESH: beta-Lactamases/chemistry ,MESH: Bacterial Proteins/genetics ,Microbiology ,beta-Lactamases ,web ,Bacterial genetics ,03 medical and health sciences ,models ,Antibiotic resistance ,Bacterial Proteins ,Drug Resistance, Bacterial ,medicine ,Microbiome ,[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology ,030304 developmental biology ,030306 microbiology ,Cell Biology ,medicine.disease ,Gastrointestinal Microbiome ,Resistome ,Computational biology and bioinformatics ,MESH: beta-Lactamases/genetics ,MESH: Drug Resistance, Bacterial/genetics ,MESH: Bacteria/classification ,identification ,Mobile genetic elements ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] - Abstract
The intestinal microbiota is considered to be a major reservoir of antibiotic resistance determinants (ARDs) that could potentially be transferred to bacterial pathogens via mobile genetic elements. Yet, this assumption is poorly supported by empirical evidence due to the distant homologies between known ARDs (mostly from culturable bacteria) and ARDs from the intestinal microbiota. Consequently, an accurate census of intestinal ARDs (that is, the intestinal resistome) has not yet been fully determined. For this purpose, we developed and validated an annotation method (called pairwise comparative modelling) on the basis of a three-dimensional structure (homology comparative modelling), leading to the prediction of 6,095 ARDs in a catalogue of 3.9 million proteins from the human intestinal microbiota. We found that the majority of predicted ARDs (pdARDs) were distantly related to known ARDs (mean amino acid identity 29.8%) and found little evidence supporting their transfer between species. According to the composition of their resistome, we were able to cluster subjects from the MetaHIT cohort (n = 663) into six resistotypes that were connected to the previously described enterotypes. Finally, we found that the relative abundance of pdARDs was positively associated with gene richness, but not when subjects were exposed to antibiotics. Altogether, our results indicate that the majority of intestinal microbiota ARDs can be considered intrinsic to the dominant commensal microbiota and that these genes are rarely shared with bacterial pathogens., The project was funded in part by the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) under grant agreement number 282004, EvoTAR. IRYCIS authors acknowledge the European Development Regional Fund ‘A way to achieve Europe’ for co-founding the Spanish R&D National Plan 2012–2019 Work (PI15-0512), CIBER (CIBERESP; CB06/02/0053) and the Government of Madrid (InGeMICS- B2017/BMD-3691). V.F.L. was further funded by a Research Award Grant 2016 of the European Society for Clinical Microbiology and Infectious Diseases.
- Published
- 2019